Abstract: System and method to reduce risk of patient infections (HAI), using operating rooms (chambers) equipped with suitable automatic airborne sterilizing agent generators, sensors, mechanisms, automatic air control devices, and laminar flow devices. After suitable safety checks, the system isolates the interior air from external air, and activates an air phase anti-microbial agent generator, filling the room with an air-phase anti-microbial agent. After sterilization, the invention deactivates the generator then restores the connection to outside sterilized air. The chamber also comprises an intelligent platform comprising video cameras, and computer vision systems configured to identify humans and medical supplies, read optical tags, and correlate recognized objects with RFID tag data.
Type:
Grant
Filed:
July 25, 2019
Date of Patent:
January 18, 2022
Assignee:
SYNERGY MED GLOBAL DESIGN SOLUTIONS, LLC
Inventors:
Sanford M. Kellogg, Jr., Thomas George Hudson
Abstract: A kit for separating and concentrating body fluid cells is provided. The kit includes a first sealing cap provided with a first close contact body; a first cap connection housing having a first inner connection body in which a first elastic body having a first slit line formed at an end thereof, with which the first close contact body comes into elastic contact when coupled to the first sealing cap, is inserted and disposed in an inner hole so that the first inner connection body is assembled with the first sealing cap; a first housing having one end screw-coupled to the first cap connection housing, and having an inner partition wall formed therein so that a first connection hole corresponding to the inner hole is formed through the inner partition wall; a central housing having one end screw-coupled to the other end of the first housing.
Abstract: The invention relates to the application of photon energy to energize dental materials to enhance their physical handling characteristics, efficacy, ability to be delivered, reactivity, polymerization, and/or post-cure mechanical properties, among other attributes.
Abstract: A silver-indium transient liquid phase method of bonding a semiconductor device and a heat-spreading mount, and a semiconductor structure having a silver-indium transient liquid phase bonding joint are provided. With the ultra-thin silver-indium transient liquid phase bonding joint formed between the semiconductor device and the heat-spreading mount, its thermal resistance can be minimized to achieve a high thermal conductivity. Therefore, the heat spreading capability of the heat-spreading mount can be fully realized, leading to an optimal performance of the high power electronics and photonics devices.
Abstract: An atrial appendage occluder capable of entering a half-released state by means of pushing a head-end fiber comprises: an occlude body (1); a head-end control fiber (2); and a tail-end control fiber (3). A head end of the occluder body (1) is connected to one end of the head-end control fiber (2) by means of a head-end threaded bushing (4). A tail end of the occluder body (1) is connected to one end of the tail-end control fiber (3) by means of a tail-end threaded bushing (5). The tail-end control fiber (3) is in the form of a hollow column. The other end of the head-end control fiber (2) sequentially passes through the tail-end threaded bushing (5) and the tail-end control fiber (3). The occluder body (1) is in a woven-net support structure, and has a shape preconfigured to match the structure of an atrial appendage after the occluder body (1) has been fully released. The occluder body (1) is in the form of a strip and disposed in an outer sheath (6) before being released.
Type:
Grant
Filed:
December 20, 2016
Date of Patent:
January 4, 2022
Assignee:
BEIJING MED ZENITH MEDICAL SCIENTIFIC CO., LTD.
Inventors:
Qingliang Zhou, Jinshan Li, Jian Meng, Danian Ke
Abstract: The invention relates to a composition, preferably a pest repellent composition, comprising thymol and/or cembratriene-ol (CBT-ol), a stabilizer and a solvent.
Type:
Application
Filed:
November 8, 2019
Publication date:
December 30, 2021
Applicant:
Mother Earth Dermatics (MED) GMBH
Inventors:
Samer Younes, Elias Kassab, Thomas Brück
Abstract: A noise cancelling system is described for a in a patient implantable hearing implant system. An implantable microphone senses a sound signal present at the microphone that includes a sound source component from a sound source external to the patient, and a noise component from internal bone conduction. At least one implantable noise sensing element is located near the microphone to sense the noise component. A filter is controlled by an adaptive algorithm responsive to transform the noise component and outputs a transducer control signal. A bone conduction transducer receives the transducer control signal and generates a corresponding mechanical vibration signal to the skull bone. The adaptive algorithm controls the filter so that the mechanical vibration signal of the bone conduction transducer offsets the noise component sensed by the at least one noise sensing element so as to minimize the noise component sensed by the implantable microphone.
Abstract: An intra-oral device comprising upper and lower jaw applicators, the upper jaw applicator comprising upper left and upper right components, and the lower jaw applicator comprising lower left and lower right components; a transverse adjustment mechanism for simultaneously adjusting a distance between the upper left and upper right components, and the lower left and lower right components wherein the transverse adjustment mechanism comprises: a threaded rod having one end portion engageable with the upper left and lower left components, and another end portion engageable with the upper right and the lower right components.
Abstract: A fabric or mesh construct, and process for making same, which allows for early wound stability and then transitions to a more compliant state exhibiting a substantially constant macro-porous pore structure through the life of the implant to promote good tissue incorporation without bridging.
Type:
Grant
Filed:
November 4, 2016
Date of Patent:
December 14, 2021
Assignee:
POLY-MED, INC.
Inventors:
Michael Scott Taylor, Seth Dylan McCullen, Kenneth W. Clinkscales, Georgios T. Hilas
Abstract: Absorbable barrier composites are designed for modulated gas and water permeability depending on clinical use and are formed of at least two physicochemically distinct components, one of which is a film adjoined to a knitted mesh and/or electrostatically spun, non-woven fabric. Depending on the physicochemical properties of the barrier composite, it can be used in neurological and urinogenital surgical procedures as well as tissue engineering and/or as physical barriers to prevent adhesion formation following several types of surgical procedures.
Abstract: A combined and/or composite resting structure comprising a mattress suitable to be normally disposed on a net anchored to a support structure to define a bed on which a person sleeps or rests and at least one mattress cover coupled on top of the mattress through a connector. In particular, the mattress cover comprises at least two padded linen items, facing and opposite each other and mutually connected through a main junction in such a way as to define between the linen items at least one hygroscopic interstitial air chamber which identifies a free volume and is suitable for imparting breathability and thermoregulation to the combined resting structure.
Abstract: An alignment guide for acetabular implants is designed to fit a particular patient using 3D medical imagery, conforms to the patient and uses one or more guide holes to direct the insertion of a positioning pin to indicate the correct positioning of various surgical tools during a medical procedure.
Abstract: The present disclosure discloses compositions comprising a hyaluronidase, devices comprising such compositions, as well as methods and uses employing such compositions and devices to reduce or eliminate a hyaluronic acid-induced blockage of one or more blood vessels supplying an eye of an individual; methods and uses for employing such compositions and devices to reduce or inhibit a vascular occlusion in an eye of an individual; and methods and uses for employing such compositions and devices to reduce or inhibit a hyaluronic acid-induced loss of vision of an individual.
Abstract: A signal processing arrangement generates optical stimulation signals to optical stimulation contacts in an implanted cochlear implant array. An input sound signal is transformed into band pass signals that each represent an associated band of audio frequencies, with each band pass signal includes an envelope component characterizing loudness of the band pass signal, and a fine structure component characterizing temporal details of the band pass signal. One or more of the signal components of each band pass signal is half wave rectified to remove negative phase signals. Signal slope is determined that corresponds to rate of change of the rectified one or more signal components. Then constant-rate optical stimulation pulses are generated for one or more given band signals only when the rectified one or more signal components has a positive signal slope.
Abstract: The present invention relates to an apparatus for nucleic acid amplification and, more particularly, to an apparatus for nucleic acid amplification capable of rapid nucleic acid amplification by rapidly heating and cooling a reactant in a reaction vessel for a chemical/biochemical reaction requiring a temperature change, and a method for temperature control in nucleic acid amplification.
Type:
Grant
Filed:
January 12, 2018
Date of Patent:
November 16, 2021
Assignees:
U-GENE & CELL CO., BODITECH MED INC.
Inventors:
Byoung Yeon Won, Sanghyun Park, Youn Tae Im, Jae Un An, Bong Kyu Lee, Jae-ho Lee, Hanseung Jeong
Abstract: The invention relates to a device (10) and to a method for electric stimulation. Said device comprises a stimulator (12) which comprises a multi-channel electrode arrangement with several stimulation electrodes (E1-E12). Said device also comprises a processor (18) which determines the pulse rate and the pulse amplitude for each stimulation electrode (E1-E12), and which controls the electrode arrangement for releasing stimulation impulses of the determined pulse rate and pulse amplitude. Said processor (18) determines the pulse rate for each stimulation electrode (E1-E12) dependent on the position in the cochlea. The invention also relates to a computer program product by means of which a data processing system determines the pulse rate for each stimulation electrode (E1-E12) dependent on the actual position thereof.
Abstract: A system for generating cold plasma is presented, suitable for use in in-vivo treatment of biological tissue. The system comprising: a control unit connectable to an elongated member at a first proximal end of the elongated member. The elongated member comprises a plasma generating unit at a second distal end thereof and gas and electricity transmission channels extending from said first proximal end towards said plasma generating unit. The control unit comprises a gas supply unit configured to provide predetermined flow rate of selected gas composition through said gas transmission channel and a power supply unit configured to generate selected sequence of high-frequency electrical pulses, typically in mega Hertz range, directed through said electricity transmission channel, thereby providing power and gas of said selected composition to the plasma generating unit for generating cold plasma.
Type:
Application
Filed:
May 13, 2021
Publication date:
November 4, 2021
Applicants:
Technion Research & Development Foundation Limited, Rambam Med-Tech Ltd.
Abstract: A plug delivery system and method of use. The plug delivery device includes a support leg, a plunger, and an extractor. The support leg includes an internal receiving space configured to receive an implanted coaxial needle assembly through an opening in the distal end. The plunger extends at least partially through the internal receiving space of the support leg and has a longitudinally adjustable relation with respect to the support leg. The extractor is also configured to translate in a longitudinal direction with respect to the support leg and has a needle connection component configured to engage the coaxial needle assembly. The extractor can be moved distally in the longitudinal direction to engage the coaxial needle assembly and then moved distally to concurrently retract the coaxial needle assembly while the plunger remains relatively stationary to deploy the sealant plug residing in the coaxial needle assembly.
Type:
Grant
Filed:
April 13, 2021
Date of Patent:
October 26, 2021
Assignee:
Med-Genesis, LLC
Inventors:
Frederick Ahari, John S. Fisher, Jon Frederick Roever
Abstract: An injectable hyaluronic acid composition including a hyaluronic acid; a local anesthetic selected from the group of amide and ester type local anesthetics or a combination thereof; and an ascorbic acid derivative in an amount which prevents or reduces the effect on the viscosity and/or elastic modulus G? of the composition caused by the local anesthetic upon sterilization by heat. Further, the medical and non-medical, such as cosmetic, use of such a composition, and to a method of manufacturing such a composition.